# A Pilot Study of the Bioavailability of Nasal Naloxone

> **NCT01939444** · PHASE2 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 5 (actual)

## Conditions studied

- Drug Overdose

## Interventions

- **DRUG:** naloxone intranasal
- **DRUG:** naloxone intravenous

## Key facts

- **NCT ID:** NCT01939444
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-11-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939444, "A Pilot Study of the Bioavailability of Nasal Naloxone". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01939444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*